Search
Nona-arginine
go.drugbank.com/drugs/DB12648InvestigationalNona-arginine is under investigation in clinical trial NCT00264706 (PolyArginine Treated vEiN grafTs (PATENT)).
Synonyms: Nona-L-arginineNeisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen
go.drugbank.com/drugs/DB14428ApprovedInvestigationalNeisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen is a vaccine.
Tenalisib
go.drugbank.com/drugs/DB15295InvestigationalTenalisib is under investigation in clinical trial NCT03711604 (Compassionate Use Study of Tenalisib (RP6530)).
Synonyms: 3-(3-FLUOROPHENYL)-2-((1S)-1-((7H-PURIN-6-YL)AMINO)PROPYL)-4H-1-BENZOPYRAN-4-ONELetosteine
go.drugbank.com/drugs/DB08939ExperimentalLetosteine is a mucolytic used in the treatment of chronic bronchopneumopathies and related conditions.
Isopentyl 2-cyanoacrylate
go.drugbank.com/drugs/DB12630ExperimentalIsoamyl 2 Cyanoacrylate is under investigation in clinical trial NCT02698644 (Hysteroscopic Tubal Occlusion With the Use of Iso Amyl-2-cyanoacrylate).
Secretin porcine
go.drugbank.com/drugs/DB09527ApprovedWithdrawnSecretin porcine stimulates pancreatic and gastric secretions to aid in the diagnosis of pancreatic exocrine dysfunction and the diagnosis of gastrinoma.
Dinalbuphine sebacate
go.drugbank.com/drugs/DB15341InvestigationalDinalbuphine sebacate is under investigation in clinical trial NCT02468128 (A Study of Intramuscular Sebacoyl Dinalbuphine Ester for Post-Hemorrhoidectomy Pain Management).
Products: NALDEBAIN® EXTENDED RELEASE INJECTION 75MG/MLCobalt Co-60
go.drugbank.com/drugs/DB15374ExperimentalCobalt Co-60 is under investigation in clinical trial NCT02891083 (Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer).
BS-001
go.drugbank.com/drugs/DB17415InvestigationalBS-001 is a recombinant oncolytic herpes simplex virus type II (OH2) therapeutic injection (Vero cell) for human use (rHSV2hGM-CSF).
Synonyms: Recombinant Oncolytic Herpes Simplex Virus Type II (OH2) Therapeutic Injection (Vero Cell) for Human UseOlpasiran
go.drugbank.com/drugs/DB19001InvestigationalOlpasiran is under investigation in clinical trial NCT05581303 (Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (Ocean(a)) - Outcomes Trial).
Synonyms: -D-GALACTOPYRANOSYL)OXY)ETHOXY)ETHYL)CARBAMOYL)-1,23,28,33-TETRAOXO-1-SULFANYL-2,5,8,11,14,17,20,37-OCTAOXA-24,29,34-TRIAZA-1.L